background key goal hiv envelope immunogen design induce crossreact neutral antibody nab aid vaccine recipe expo strain exactly match immunogen due multiple quasispeci circus human popup worldwide heterolog ship challenge essential realist efficacy test prima ass whether polygon img iso these monkey rm highest term shining could protect topic tier shivnip virus envelope elicit result demons bind gag tat env differ clade compete broadly b rc e neutral include cell delete decrease active fold pmc assay although vitro prepare fail prevent acquisit repeat intranet london virus dose make significantly lower peak viremia p unexpectedly singlegenom analysis reveal higher number transmit variant low imply increase level complemented depend enhance infect made content similar observe plasma treat concur prima model data suggest dual role antihiv ab depend plasma upon count 